Scarica l'app Stockscreener
4.20
1.20%
0.05
Dopo l'orario di chiusura:
4.24
0.04
+0.95%
Tuhura Biosciences Inc Borsa (HURA) Ultime notizie
Is TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical Study - Quantisnow
Equities Analysts Offer Predictions for HURA Q3 Earnings - Defense World
HURA: 2024 Financial Results - Zacks Small Cap Research
TuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual Meeting - PR Newswire
TuHURA Biosciences hires new EVP for drug development By Investing.com - Investing.com South Africa
TuHURA Biosciences hires new EVP for drug development - Investing.com India
Tuhura Biosciences Appoints Dr. Bertrand Le Bourdonnec As Executive Vice President - MarketScreener
TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management - PR Newswire
Q2 EPS Estimate for TuHURA Biosciences Increased by Analyst - Defense World
Q3 Earnings Estimate for HURA Issued By HC Wainwright - Defense World
HC Wainwright Has Lowered Expectations for TuHURA Biosciences (NASDAQ:HURA) Stock Price - Defense World
H.C. Wainwright cuts TuHURA Biosciences target to $12; Keeps Buy By Investing.com - Investing.com South Africa
H.C. Wainwright cuts TuHURA Biosciences target to $12; Keeps Buy - Investing.com
Is TuHURA Biosciences (NASDAQ:HURA) In A Good Position To Deliver On Growth Plans? - Yahoo
Charles Schwab Investment Management Inc. Purchases New Position in TuHURA Biosciences (NASDAQ:HURA) - Defense World
TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 - TradingView
TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update - PR Newswire
TuHURA Biosciences (NASDAQ:HURA) Stock Price Up 1.7% – Still a Buy? - Defense World
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
TuHURA Biosciences Announces Acquisition of Kineta, Inc. - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
TuHURA Biosciences Expands Board with New Appointment - TipRanks
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors - Joplin Globe
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference - Eagle-Tribune
What is HC Wainwright’s Estimate for HURA Q2 Earnings? - Defense World
KINETA, INC./DE SEC 10-K Report - TradingView
TuHURA Biosciences (NASDAQ:HURA) Now Covered by Analysts at HC Wainwright - Defense World
HC Wainwright Initiates TuHURA Biosciences at Buy With $13 Price Target -March 03, 2025 at 07:29 am EST - Marketscreener.com
TuHURA Biosciences (HURA) to Release Earnings on Wednesday - Defense World
TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Milton Daily Standard
Press Release Distribution & PR Platform - ACCESS Newswire
Apollon Wealth Management LLC Invests $253,000 in TuHURA Biosciences (NASDAQ:HURA) - MarketBeat
TuHURA Biosciences: A Hold On Only The Faintest Glimmers Of Efficacy (NASDAQ:HURA) - Seeking Alpha
TuHURA Biosciences secures $3M through warrant exercises By Investing.com - Investing.com Australia
TuHURA Biosciences secures $3M through warrant exercises - Investing.com India
0.15%
4.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):